Tue, April 19, 2022

Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $7 on, Apr 19th, 2022

Michael Ng of Goldman Sachs, Maintained "Blend Labs, Inc." (BLND) at Strong Buy with Decreased Target from $8 to $7 on, Apr 19th, 2022.

Michael has made no other calls on BLND in the last 4 months.



There are 7 other peers that have a rating on BLND. Out of the 7 peers that are also analyzing BLND, 6 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Bhavan Suri of "William Blair" Downgraded from Buy to Hold on, Monday, April 4th, 2022
  • Joseph Vafi of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Friday, April 1st, 2022
  • Michael Turrin of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $5 on, Friday, April 1st, 2022
  • Arvind Ramnani of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $5.5 on, Friday, April 1st, 2022
  • Terry Tillman of "Truist Securities" Maintained at Hold with Decreased Target to $5.5 on, Friday, April 1st, 2022
  • Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022


This is the rating of the analyst that currently disagrees with Michael


  • Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $6 on, Friday, April 1st, 2022